Logo
x

Search

Subscribe Now

develop

I-Mab Entered into a Collaboration with Jumpcan to Develop and Commercialize Eftansomatropin Alfa (TJ101) in Mainland China

I-Mab Entered into a Collaboration with Jumpcan to Develop and Commercialize Eftansomatropin Alfa (TJ101) in Mainland China

  • November 11, 2021
Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases

Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases

  • October 27, 2021
Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases

Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases

  • October 27, 2021
Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Therapeutics

Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Th...

  • October 21, 2021
Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS Disorders

Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS...

  • October 21, 2021
Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

  • October 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.